Bicycle Therapeutics (BCYC) Other Accumulated Expenses (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Other Accumulated Expenses data on file, last reported at $160000.0 in Q2 2026.

• Quarterly Other Accumulated Expenses fell 32.2% year-over-year to $160000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $160000.0 (down 32.2% YoY) and the FY2025 annual result came in at $136000.0, down 54.21% from the prior year.
• Other Accumulated Expenses eased to $160000.0 in Q2 2026, from $483000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.5 million in Q4 2022 to a low of $136000.0 in Q4 2025.
• A 5-year average of $485388.9 and a median of $346500.0 in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 1396.88% — and 2023, when it slumped 82.54%.
• Tracing BCYC's Other Accumulated Expenses over 5 years: stood at $1.5 million in 2022, then slumped by 82.54% to $257000.0 in 2023, then rose by 15.56% to $297000.0 in 2024, then sank by 54.21% to $136000.0 in 2025, then increased by 17.65% to $160000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $160000.0 (Q2 2026), $483000.0 (Q1 2026), and $136000.0 (Q4 2025), per Business Quant data.